Fig. 7: Predicted drug sensitivity analysis between high-BCIS and low-BCIS. | Cell Death Discovery

Fig. 7: Predicted drug sensitivity analysis between high-BCIS and low-BCIS.

From: Development of a breast cancer invasion score to predict tumor aggressiveness and prognosis via PI3K/AKT/mTOR pathway analysis

Fig. 7

A Sensitivity comparison of Tamoxifen, Vinblastine, and Methotrexate between high-BCIS and low-BCIS. B Sensitivity differences to Sorafenib, Crizotinib, and Imatinib between high-BCIS and low-BCIS. C Predicted sensitivity to Temsirolimus, Pazopanib, and Tipifarnib across high-BCIS and low-BCIS.

Back to article page